Larvol Delta - Aptinyx-Completes-Enrollment-in-Phase-2b-Study-of-NYX2925-in-Fibromyalgia

NYX-2925 - Aptinyx

https://www.businesswire.com/news/home/20220228005255/en/Aptinyx-Completes-Enrollment-in-Phase-2b-Study-of-NYX-2925-in-Fibromyalgia

Feb 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next